Quick answer: The cheapest tirzepatide in 2026 is $25/month through the Eli Lilly Savings Card if you have commercial insurance that covers Mounjaro or Zepbound. Cash-pay options start at $299–$449/month via LillyDirect for Zepbound vials, $499/month with the Lilly card if you're uninsured, and $149–$400/month through compounded tirzepatide in medical-exception cases. Always confirm coverage with your plan first.

The Price Problem

Tirzepatide is one of the most effective FDA-approved medications studied for chronic weight management. In SURMOUNT-1, adults at higher tirzepatide doses lost approximately 20% or more of baseline body weight over 72 weeks, though individual results vary. But at retail pricing historically above $1,000 per month, most people cannot afford it at sticker price.

Key Takeaways
  • Brand-name tirzepatide (Mounjaro/Zepbound) has historically retailed above $1,000/month; cash prices vary by pharmacy, dose, and current manufacturer programs
  • Eli Lilly's savings card drops it to ~$499/month for uninsured, or $25/month with commercial insurance
  • Compounded tirzepatide is restricted to medical-exception cases (FDA resolved the tirzepatide shortage on December 19, 2024); LillyDirect self-pay starts around $299/month for the lowest-dose vial, with higher doses costing more
  • Costco and LillyDirect sometimes offer lower retail prices than chain pharmacies

The good news: almost nobody actually pays retail. Between manufacturer programs, compounding pharmacies, and telehealth providers, there are multiple paths to affordable tirzepatide. Here is every option, ranked from cheapest to most expensive.

Price Comparison Table

Option Monthly Cost Medication Type Insurance Needed?
Lilly Savings Card (insured) $25/mo Brand-name Yes (commercial)
Compounded tirzepatide (exception cases, telehealth) $149-400/mo Compounded No
LillyDirect $299-449/mo Brand-name No
Lilly Savings Card (plan doesn't cover) ~$499/mo Brand-name Yes (commercial, plan excludes coverage)
Costco retail $900-1,000/mo Brand-name No
Chain pharmacy retail $1,000-1,200/mo Brand-name No

Option 1: Lilly Savings Card ($25/month with insurance)

If you have commercial health insurance that covers tirzepatide, Eli Lilly's savings card brings your copay down to as low as $25 per 28-day supply. This is the cheapest way to get brand-name tirzepatide, period.

How to get it:

  • Visit the Zepbound or Mounjaro savings page on lilly.com
  • Complete the registration form
  • Present the digital card at your pharmacy along with your insurance card

Who qualifies:

  • Must have commercial (private) health insurance
  • Must have a valid prescription
  • Must be a US resident age 18+

Who does not qualify:

  • Medicare, Medicaid, or TRICARE beneficiaries
  • Patients with government-funded insurance
  • Patients whose insurance excludes the savings card through a copay accumulator program

Important note: Some insurance plans use copay accumulator programs, which means the savings card payment does not count toward your deductible or out-of-pocket maximum. Ask your pharmacist if your plan does this.

Option 2: LillyDirect ($299-449/month)

Eli Lilly launched LillyDirect as a self-pay option for brand-name tirzepatide without going through insurance. You order directly through Lilly's platform and the medication ships to your home. Current self-pay pricing starts around $299 per month for the lowest-dose vial (2.5 mg), with higher doses costing more; verify current pricing for your prescribed dose before starting.

This is a relatively new program and pricing has shifted since launch. It is worth checking the current LillyDirect pricing, as Lilly has been adjusting rates over time.

Option 3: Lilly Savings Card (Insurance Doesn't Cover, ~$499/month)

For commercially insured patients whose plan does not cover Zepbound, the Lilly Savings Card may reduce the cash price to around $499 per month, though eligibility rules apply. Patients without any commercial insurance may not qualify for the same savings-card terms.

This is significantly more than the insured-with-coverage savings card rate, but gives you the FDA-approved, brand-name product manufactured by Eli Lilly.

Option 4: Costco Pharmacy

Costco consistently offers some of the lowest retail prices for prescription medications. You do not need a Costco membership to use their pharmacy in most states. Tirzepatide at Costco typically runs $900-1,000/month, which is $100-200 less than chain pharmacies.

Worth checking if you are paying retail and want the brand-name product. Use GoodRx or similar tools to compare Costco pricing against your local options.

⚠️Important

Compliance note on compounded tirzepatide. Compounded tirzepatide is not FDA-approved. Its availability depends on FDA-determined shortage status, pharmacy compliance with state and federal compounding rules, and documented patient-specific medical need. Patients should avoid products sold without a prescription or from non-licensed sources, and should not assume compounded tirzepatide is equivalent to Mounjaro or Zepbound.

Option 5: Compounded Tirzepatide (Medical-Exception Cases, $149-400/month)

The FDA determined that the tirzepatide injection shortage was resolved on December 19, 2024. New compounded tirzepatide prescriptions are now restricted to specific medical-exception cases at licensed compounding pharmacies (such as documented intolerance to the commercial formulation or allergy to inactive ingredients). Several telehealth programs still offer it under those exception criteria.

Compounded tirzepatide from 503A and 503B pharmacies may still be available through licensed telehealth providers for patients who qualify under those exception criteria. Programs typically include the medication, provider consultations, and ongoing monitoring. Pricing varies widely by provider, dose, pharmacy source, included clinical services, and current regulatory status; verify current pricing directly with the provider before signing up.

What is compounded tirzepatide?

Compounding pharmacies create custom preparations of tirzepatide. These are not generic medications and they are not FDA-approved. Compounded products may be intended to contain tirzepatide, but they may differ from brand-name products in formulation, concentration, sterility standards, delivery method, and quality-control oversight. The FDA allows compounding when a commercially available product does not meet a patient's specific medical needs (such as allergy to inactive ingredients or documented intolerance to the commercial formulation). Tirzepatide was previously available more broadly under shortage-list rules, but the FDA resolved the shortage on December 19, 2024.

Things to check before choosing a compounding provider:

  • Is the pharmacy 503A or 503B licensed?
  • Does the provider include medical consultations in the price?
  • What happens if you need a dose adjustment?
  • Are there cancellation fees?

Take our provider quiz to find a provider that fits your situation and budget.

Insurance Coverage: Mounjaro vs. Zepbound

Mounjaro and Zepbound contain the same active ingredient (tirzepatide) but are approved for different indications:

  • Mounjaro is approved for type 2 diabetes
  • Zepbound is approved for chronic weight management

Insurance plans often cover Mounjaro for type 2 diabetes more readily than Zepbound for chronic weight management. The prescribed product should match the patient's diagnosis, clinical indication, and the insurer's coverage criteria — this is a decision for the prescriber based on the patient's actual condition, not a coverage-shopping exercise.

See our insurance coverage guide for insurer-specific details.

The Bottom Line

Patients should explore insurance coverage, manufacturer programs, and legitimate self-pay options before paying full retail for tirzepatide. If you have commercial insurance that covers tirzepatide, the Lilly Savings Card at $25/month is the lowest-cost path. If your plan does not cover it, LillyDirect self-pay for brand Zepbound (from $299 per month for the lowest-dose vial, higher doses more) is the clearest cash-pay option for most patients in 2026. Compounded tirzepatide remains available through licensed telehealth providers for patients who qualify under medical-exception criteria after the December 2024 FDA shortage resolution, but it is not FDA-approved and should not be presented as equivalent to Mounjaro or Zepbound.

Use our cost guide for a full breakdown of all GLP-1 medication pricing, or compare telehealth providers to explore your options. For most patients seeking cash-pay tirzepatide in 2026, LillyDirect self-pay is the recommended starting point.

💡Pro Tip

Always compare GLP-1 providers by total monthly cost at your maintenance dose, not the advertised starting price. Factor in consultation fees, required lab work, and shipping charges. Month-to-month plans give you flexibility to switch if better options emerge.

How Tirzepatide Compares to Other GLP-1 Options

Tirzepatide (sold as Zepbound for chronic weight management and Mounjaro for type 2 diabetes) targets both GLP-1 and GIP receptors, which is why it tends to produce more weight loss than semaglutide-only medications. In SURMOUNT-1, adults with obesity or overweight and weight-related complications lost approximately 20% or more of baseline body weight at higher tirzepatide doses over 72 weeks, though individual results vary. In comparison, the STEP 1 trial of semaglutide (Wegovy/Ozempic) showed approximately 14.9% average weight loss over a similar duration.

If tirzepatide is still too expensive, semaglutide alternatives include compounded semaglutide (from $99 per month), brand-name Wegovy through NovoCare ($349 per month self-pay), or the new Wegovy oral pill ($149 per month at starter doses). Non-GLP-1 options like Contrave and Xenical are cheaper but produce less weight loss. The newest oral GLP-1, Foundayo (orforglipron), launched in April 2026 at $149 per month.

Sources

  1. Eli Lilly Zepbound Savings Program
  2. SURMOUNT-1 Clinical Trial Results, NEJM 2022
  3. FDA Compounding Policy

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Individual results vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you are experiencing a medical emergency, call 911.